Biosimilars: Cost-Efficiency and Adoption Trends in the GCC Biologics Market region
The adoption of biosimilars is a critical market trend transforming the cost structure and accessibility of complex biologic therapies across the GCC Market region. Biosimilars, highly similar versions of already approved reference Product types, offer a path to treating chronic conditions like rheumatoid arthritis, diabetes, and certain cancers at a significantly lower...
0 Comments 0 Shares 254 Views 0 Reviews